P018 Afatinib Named Patient Use Program in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers
Year: 2018
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: G. Chang, D.C. Lam, C. Tsai, Y. Chen, J. Shih, S. Aggarwal, S. Wang, S. Kim, Y. Kim, I. Wahid, R. Li, W. Lim, V. Sriuranpong, T.T. Chan, J.C. Yang, C. Yu, W. Liao, C. Ho, R.M. Lorence, P. Carriere, C. Raabe, A. Cseh, K. Park
Institutions: Taichung Veterans General Hospital, Queen Mary Hospital, University of Hong Kong, Taipei Veterans General Hospital, National Taiwan University Hospital, Sir Ganga Ram Hospital, Peking University Cancer Hospital, Asan Medical Center, University of Ulsan, Chonnam National University Hwasun Hospital, St. Luke's Medical Center, National Cancer Centre Singapore, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Boehringer Ingelheim (Austria), Samsung Medical Center, Sungkyunkwan University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2904532756